Loading...
XLONDOCS
Market cap884mUSD
Dec 23, Last price  
73.30GBP
1D
-0.34%
1Q
36.75%
IPO
-83.67%
Name

Dr Martens PLC

Chart & Performance

D1W1MN
XLON:DOCS chart
P/E
1,019.62
P/S
80.44
EPS
0.07
Div Yield, %
0.08%
Shrs. gr., 5y
-0.29%
Rev. gr., 5y
14.06%
Revenues
877m
-12.32%
163,904,000235,300,000232,400,000290,600,000348,600,000454,400,000672,200,000773,000,000908,300,0001,000,300,000877,100,000
Net income
69m
-46.31%
-32,000,000200,000-12,000,000-11,300,000-5,700,00017,200,00074,800,00034,700,000181,200,000128,900,00069,200,000
CFO
168m
+134.17%
5,024,00019,800,00025,800,00034,400,00046,000,00056,000,000116,000,000146,100,000173,600,00071,700,000167,900,000
Dividend
Mar 06, 20250.85 GBP/sh
Earnings
May 28, 2025

Profile

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
URL
https://www.drmartensplc.com/
IPO date
Jan 29, 2021
Employees
2,591
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
877,100
-12.32%
1,000,300
10.13%
908,300
17.50%
Cost of revenue
374,200
436,400
366,200
Unusual Expense (Income)
NOPBT
502,900
563,900
542,100
NOPBT Margin
57.34%
56.37%
59.68%
Operating Taxes
23,800
30,500
33,100
Tax Rate
4.73%
5.41%
6.11%
NOPAT
479,100
533,400
509,000
Net income
69,200
-46.31%
128,900
-28.86%
181,200
422.19%
Dividends
(57,800)
(58,400)
(12,200)
Dividend yield
6.68%
4.10%
0.51%
Proceeds from repurchase of equity
(50,500)
BB yield
5.84%
Debt
Debt current
55,400
28,100
19,800
Long-term debt
603,900
417,700
405,200
Deferred revenue
124,300
Other long-term liabilities
6,300
4,400
95,000
Net debt
547,200
287,300
31,800
Cash flow
Cash from operating activities
167,900
71,700
173,600
CAPEX
(18,200)
(51,400)
(25,000)
Cash from investing activities
(25,500)
(52,200)
(25,000)
Cash from financing activities
(185,900)
(92,300)
(36,200)
FCF
432,700
337,300
421,900
Balance
Cash
111,100
157,500
228,000
Long term investments
1,000
1,000
165,200
Excess cash
68,245
108,485
347,785
Stockholders' equity
1,757,200
404,200
328,200
Invested Capital
783,255
744,515
388,800
ROIC
62.72%
94.13%
134.71%
ROCE
58.87%
65.97%
75.61%
EV
Common stock shares outstanding
985,600
1,001,200
1,002,900
Price
0.88
-38.33%
1.42
-40.41%
2.39
-47.31%
Market cap
864,864
-39.30%
1,424,708
-40.51%
2,394,925
-47.18%
EV
1,412,064
1,712,008
2,426,725
EBITDA
575,200
618,100
578,800
EV/EBITDA
2.45
2.77
4.19
Interest
32,200
18,700
15,000
Interest/NOPBT
6.40%
3.32%
2.77%